MEI Pharma Inc. | Income Statement
Fiscal year is July-June. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
23,249.00
1,622.00
Cost of Goods Sold (COGS) incl. D&A
50.00
64.00
58.00
5,000.00
3,383.00
Gross Income
50.00
64.00
58.00
18,249.00
1,761.00
SG&A Expense
27,178.00
32,707.00
20,946.00
15,865.00
26,825.00
EBIT
27,228.00
32,771.00
21,004.00
2,384.00
28,586.00
Unusual Expense
-
-
-
-
9,705.00
Non Operating Income/Expense
-
-
-
-
2,367.00
Pretax Income
27,147.00
32,693.00
20,861.00
2,671.00
40,067.00
Income Tax
1.00
1.00
1.00
1.00
1.00
Consolidated Net Income
27,148.00
32,694.00
20,862.00
2,670.00
40,068.00
Net Income
27,148.00
32,694.00
20,862.00
2,670.00
40,068.00
Net Income After Extraordinaries
27,148.00
32,694.00
20,862.00
2,670.00
40,068.00
Net Income Available to Common
27,148.00
32,694.00
20,862.00
2,670.00
40,068.00
EPS (Basic)
1.35
1.16
0.61
0.07
0.97
Basic Shares Outstanding
20,061.40
28,204.40
34,400.40
36,813.00
41,431.00
EPS (Diluted)
1.35
1.16
0.61
0.07
0.97
Diluted Shares Outstanding
20,061.40
28,204.40
34,400.40
36,938.00
41,431.00
EBITDA
27,178.00
32,707.00
20,946.00
2,469.00
28,533.00
Non-Operating Interest Income
81.00
78.00
143.00
287.00
591.00
About MEI Pharma
View Profile
